Co-founded in 2016 by 2 PhD molecular biologists, one of them with over 26 year experience in the aptamer field, the French start-up develops biotechnological products. Its main activity is dedicated to the selection, characterization, optimization and functionalization of custom oligonucleotide aptamers, which are usually called nucleic acid antibodies. Very few companies in the world can develop such aptamer-based tools, in this emerging market. The French start-up employs engineers, PhDs and post-docs and already deals with foreign partners.

The company, located in France, is an expert of the distribution of LNG (Liquid Natural Gas) and bio-LNG, which is an alternative fuel, particularly suitable for heavy goods vehicles on international trips. The company is owned and managed by a team of professionals with 10 years' experience in the LNG distribution. In 2020 the turnover was just below 1 million euros. The company's flagship product is a refuelling card dedicated to LNG trucks. Haul transporters who need to refuel in many points during their journeys across various European countries do find it very useful.

A French SME specialized in software programming and digitalization services offers an electronic laboratory notebook for laboratories and R&D structures. R&D organizations have to deal with challenges related to scientific integrity, capitalization of knowledge and management of scientific data. Digitalizing their laboratory notebook can be a concrete answer to that as it gives the ability to simplify access to reliable information, improve their competitiveness and boost innovation. The R&D project management is very complex.

Founded in 2011, the French Company is a French service provider or CRO (Contract Research Organisation), in the field of production, purification, formulation, and characterization of proteins. The cell-free "technology" makes it possible to provide solutions to the main problems encountered with cellular expression: inclusion bodies, truncated proteins, unstable and cytotoxic proteins for example. From this technology, It is possible to express quickly and in quantity SIMPLE as DIFFICULT proteins.